+3S
Serum Biotech is a high-tech enterprise specialized in research, development, production, and sales of antitoxin and antiserum products in China.
+3S
Industry:
Biotechnology Manufacturing Medical Pharmaceutical
Founded:
1999-11-09
Address:
Qingpu, Shanghai, China
Country:
China
Website Url:
http://www.serum-china.com.cn
Total Employee:
101+
Status:
Active
Contact:
+86 400 016 9995
Total Funding:
100 M CNY
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sanofi
Sanofi is engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions.
Current Employees Featured
Zhihe Fan Chairman & Founder @ +3S
Chairman & Founder
Founder
Stock Details
Investors List
Ch-gemstone capital
Ch-gemstone capital investment in Post-IPO Equity - +3S
Optical Valley Venture Capital
Optical Valley Venture Capital investment in Post-IPO Equity - +3S
Tianxing Capital
Tianxing Capital investment in Post-IPO Equity - +3S
Tibet Jiuzheng Capital Investment
Tibet Jiuzheng Capital Investment investment in Post-IPO Equity - +3S
Real Power Capital
Real Power Capital investment in Post-IPO Equity - +3S
TFTR Investment
TFTR Investment investment in Post-IPO Equity - +3S
Zheshang Securities
Zheshang Securities investment in Post-IPO Equity - +3S
Shenwan Hongyuan
Shenwan Hongyuan investment in Post-IPO Equity - +3S
Official Site Inspections
http://www.serum-china.com.cn
- Host name: 103.40.192.217
- IP address: 103.40.192.217
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "+3S"
serum-china.com.cn
Shanghai Serum Bio-technology Co., LTD. Address factory: 1288 Hua Qing Rd. Qingpu district. 201707 Shanghai, PRCSee details»
赛伦生物-专业从事生物医药高新技术企业
赛伦生物获批建立院士专家工作站. 近日，上海市院士专家工作站指导办公室发布《关于批准建立2017年度第五批院士专家工作站的通知》，赛伦生物等11家企事业单位获批建立院士专家工作站。See details»
公司概况_ - serum-china.com.cn
公司全称： 上海赛伦生物技术股份有限公司. 公司英文名全称： Shanghai Serum Bio-Technology Co., Ltd. 股票代码： 688163See details»
+3S - Crunchbase Company Profile & Funding
+3S raised CN¥50,000,000 / Post Ipo Equity from Ch-gemstone capital and 5 other investors . ... Contact Email sales@serum-china.com; Phone Number +86 400 016 9995; Serum Biotech is …See details»
Shanghai Serum Bio-Technology Co., Ltd. (上海赛伦生物技术股份 …
了解Shanghai Serum Bio-Technology Co., Ltd. (上海赛伦生物技术股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 25篇新闻和1篇文献，疾病领域:感染，肿瘤， …See details»
Shanghai Serum Bio-Technology Co., Ltd. (China) - EMIS
Nov 24, 2024 Shanghai Serum Bio-Technology Co., Ltd is a high-tech biopharmaceutical enterprise specializing in the research and development, production and operation of antitoxin …See details»
Shanghai Serum Bio-Technology Company Profile - Craft
Shanghai Serum Bio-Technology ¥188.59 m in annual revenue in FY 2023. See insights on Shanghai Serum Bio-Technology including office locations, competitors, revenue, financials, …See details»
上海赛伦生物技术股份有限公司_赛伦生物公司基本信息介 …
Dmb@serum-china.com: 公司网址: www.serum-china.com.cn: 信息披露人: 成琼: 境内会计师事务所: 天职国际会计师事务所(特殊普通合伙) 注册会计师: 郭海龙、金园: 经营范围: 抗毒素、抗毒 …See details»
上海赛伦生物技术股份有限公司 - 爱企查
May 28, 2024 简介： 1、基本情况 上海赛伦生物技术股份有限公司是一家专精特新中小企业、高新技术企业(2022)，该公司成立于1999年11月09日，位于上海市青浦区华青路1288号，目前 …See details»
Serum Bio-technology - VentureRadar
Shanghai ZhenGe China Privately Held Shanghai ZhenGe Biotech Co., Ltd. is a premier high-tech enterprise registered in Shanghai (Lin-gang Special Area, Pilot Free Trade Zone of China). …See details»
An exposome atlas of serum reveals the risk of chronic ... - Nature
Mar 13, 2024 To assess the risk of chronic disease from the serum exposome, (i) we designed a cohort of 5696 healthy and chronic disease patients from 15 provinces in China; the 12 chronic …See details»
关于我们-产品质量标准和技术创新方面保持行业领先
上海赛伦生物技术股份有限公司成立于1999年，是一家主营抗毒素抗血清的生物医药高新技术企业。2022年3月11日，公司在上海证券交易所科创板挂牌上市（股票代码：688163）。See details»
Longitudinal immune profiling reveals dominant epitopes
Electronic address: jinxia@serum-china.com.cn. PMID: 35074422 PMCID: PMC8779849 DOI: 10.1016/j.jaci.2022.01.005 Abstract Background: Severe acute respiratory syndrome …See details»
An mRNA vaccine encoding Chikungunya virus E2-E1 protein …
Corresponding author: Zhihua Kou, kouzhihua@shphc.org.cn Corresponding author: Yu Wei, yuwei@ips.ac.cn Corresponding author: Xia Jin, jinxia@serum-china.com.cn; a CAS Key …See details»
China approves new COVID-19 vaccine for clinical trials
Apr 11, 2021 More than 161.12 million doses of COVID-19 vaccines had been administered across China as of Friday, the National Health Commission said Saturday. Follow …See details»
Ephraim-Fetal Bovine Serum, Peak Serum
We tested Ephraim Lifescience's Australian Origin FBS (46-500-FBS) on A549, MCA205, 293FT, HepG2,MC38,B16,HT-29,3T3L1,RAW264.7 and H460 cell lines. This serum is high quality, …See details»
An exposome atlas of serum reveals the risk of chronic ... - PubMed
Mar 13, 2024 13 University of Chinese Academy of Sciences, Beijing, 100049, China. xugw@dicp.ac.cn. 14 Liaoning Province Key Laboratory of Metabolomics, Dalian, 116023, …See details»
5th China-Central Asia Foreign Ministers' Meeting held in Chengdu
8 hours ago CHENGDU, Dec. 1 (Xinhua) -- The Fifth China-Central Asia Foreign Ministers' Meeting, held on Sunday in southwestern Chinese city of Chengdu, saw extensive discussions …See details»
Contact Us - serum-china.com.cn
Factory: 1288 Hua Qing Rd. Qingpu district. 201707 Shanghai, PRC. 24/7 hotline: 400-016-9995 . Telephone: (86 21) 6076 0783 (factory)See details»
China's spicy hotpot sets its sights on global market - China.org.cn
2 days ago [Photo/China.org.cn] The hotpot expo, the only themed exhibition at CISCE, spans 4,000 square meters and showcases the complete Sichuan-Chongqing hotpot industry chain, …See details»